Recent work indicates that mutations in a cytidine deaminase homologue ablate both immunoglobulin class switch recombination and somatic hypermutation. These findings now explain cases of autosomal hyper-IgM syndrome and reveal that critical components for key functions of B cells require RNA editing. During lymphocyte differentiation, three covalent modifications take place at the antigen receptor gene loci to generate immunological diversity. V(D)J recombination is the process by which the exon encoding the antigen-binding pocket of the receptor is assembled, occurring in B cells at the three immunoglobulin (Ig) loci (heavy chain, and kappa and lambda light chain loci) and in T cells at the three T-cell receptor loci (α/δ, γ and β loci). Class switch recombination occurs only at the Ig heavy chain locus in B cells, and it is the DNA recombination process by which production of the IgG, IgA, and IgE antibodies can occur instead of IgM. Somatic hypermutation is the process by which point mutations are introduced into the V(D)J exon in Ig genes in B cells as a way of creating additional diversity beyond the combinatorial and junctional diversity achieved by V(D)J recombination. Somatic hypermutation improves the affinity of Ig molecules, and it occurs at the Ig heavy and light chain genes [1].
During lymphocyte differentiation, three covalent modifications take place at the antigen receptor gene loci to generate immunological diversity. V(D)J recombination is the process by which the exon encoding the antigen-binding pocket of the receptor is assembled, occurring in B cells at the three immunoglobulin (Ig) loci (heavy chain, and kappa and lambda light chain loci) and in T cells at the three T-cell receptor loci (α/δ, γ and β loci). Class switch recombination occurs only at the Ig heavy chain locus in B cells, and it is the DNA recombination process by which production of the IgG, IgA, and IgE antibodies can occur instead of IgM. Somatic hypermutation is the process by which point mutations are introduced into the V(D)J exon in Ig genes in B cells as a way of creating additional diversity beyond the combinatorial and junctional diversity achieved by V(D)J recombination. Somatic hypermutation improves the affinity of Ig molecules, and it occurs at the Ig heavy and light chain genes [1] .
Although many aspects of V(D)J recombination are now well-understood, progress on the mechanistic aspects of class switch recombination and somatic hypermutation has been much more difficult. This is not entirely unexpected. The cleavage phase of V(D)J recombination is precisely at the boundary of a defined signal sequence, and the reaction mechanism falls into the well-studied category of DNA transposition [2] . In marked contrast, class switching is a regionally specific recombination process that occurs at G-rich, repetitive regions under conditions of transcription [3, 4] . There is no real precedent for this type of recombination elsewhere in biology. Likewise, somatic hypermutation is a regionally specific mutation process with no obvious precedent in other biological systems [5] .
At the DNA level, the mechanisms of class switch and somatic hypermutation have been unclear. Transcription appears to be important for class switch recombination because special promoters are present upstream of each switch region for the purpose of sending transcripts through these regions at about the time of the recombination [4] . The switch regions are several kilobases long and contain highly repetitive, G-rich sequences. RNA-DNA hybrids form at such sequences in vitro [6, 7] , but evidence for such a structure in vivo has yet to be found. Class switch recombination can occur anywhere within the several kilobases of each switch region [3] . The nuclease responsible for this process has yet to be identified, and it is also unclear what sequence or structure that nuclease might recognize. Somatic hypermutation also appears to require transcription and the presence of one of the Ig enhancers [5] . Any promoter appears to be suitable, even an RNA polymerase I promoter [8] . Recently, strand breaks have been identified in one cell line that carries out somatic hypermutation in culture, but the significance of this is not clear at this stage [9] .
The Honjo laboratory has had a longstanding role in understanding class switch recombination, identifying many of the original class switch sequences two decades ago [10] . More recently, this group carried out a cDNA subtraction analysis of a switch-stimulated and -unstimulated cell line [11] . Among three newly identified cDNAs was one with homology to the cytidine deaminase that acts on the apolipoprotein (apo) B mRNA generating a smaller isoform of the protein. The authors called this gene the activationinduced deaminase, or AID, and its expression nicely matched that of cells carrying out class switch recombination. The protein is expressed in lymph nodes and spleen, but not in thymus, brain, kidney, liver, testis, lung, heart, or muscle. The protein has the ability to convert cytidine and deoxycytidine nucleosides to uridine and deoxyuridine nucleosides. Although it was not clear what the natural target mRNA might be for AID, the discovery of an RNAediting enzyme homologue that was specific to germinal center B cells, which undergo extensive proliferation and maturation, was quite exciting in itself.
The most recent dramatic chapter to this story occurred when Honjo and colleagues [12] made a murine genetic knockout of AID. They found that the mice could not make IgG, IgA, or IgE, even when provided with a strong, specific antigenic challenge. The B cells from the mice, when stimulated in culture, were also unable to generate class-switched immunoglobulins or to show any evidence of recombination at the DNA level. Strikingly, the mice could not carry out another major DNA modificationsomatic hypermutation of their immunoglobulin genes. In some manner, therefore, AID is critical to both class switch recombination and somatic hypermutation.
Remarkably, major progress of a related nature was being made concurrently in the Durandy laboratory [13] in Paris on the human hyper-IgM syndrome, a disease characterised by a predominance of IgM antibodies. An X-linked form of hyper-IgM syndrome can be caused by a signaling defect in the CD40 ligand, which is expressed on T cells and certain other immune cells and regulates various immune functions when bound to its partner, CD40. The result is that the CD40 molecule on the B cells then fails to have a functional ligand on these other immune cells, and class switching fails to be stimulated, along with other aspects of terminal B-cell differentiation. Failure of switching results in accumulation of IgM instead of IgG, IgA or IgE. Durandy and colleagues have been studying an autosomal recessive form of hyper-IgM syndrome. In these patients, CD40 and its ligand are normally expressed, along with related signaling molecules, revealing that a different molecule is affected.
In order to track down the gene defective in the autosomal form of the syndrome, Durandy and colleagues performed linkage analysis using microsatellite markers in affected families. Their search narrowed their focus on a 4.5 cM region of chromosome 12p13, which happened to be where the Honjo group had recently mapped the AID gene in the human genome [14] . The Tokyo and Paris groups shared their information in an effort to test the AID gene in the hyper-IgM families. The Durandy laboratory sequenced the 5 exons of AID and the adjacent intronic regions in their 18 patients. Strikingly, they found 10 independent mutations among the patients, and the patterns of inheritance explained the hyper-IgM syndrome.
The immunological characteristics of the patients are interesting. In addition to being deficient in IgG, IgA or IgE and having elevated IgM, they have other abnormalities. The level of somatic hypermutation, as might be expected from the murine knockout, is markedly reduced. Histologically, the patients have markedly enlarged germinal centers. Interestingly, many of these germinal center B cells expressed not only IgM but also IgD: cells expressing this Ig type are not usually abundant in normal reactive germinal centers.
Clearly, the AID protein plays an important role in B-cell differentiation, because its absence and mutation ablates class switch recombination and somatic hypermutation and alters germinal center dynamics. The natural next question is what mRNA might this cytidine deaminase be altering to have such dramatic effects. The possibilities are all interesting, of course ( Figure 1) . First, given that the AID gene appears to be a member of the RNA-editing cytidine deaminases, it is reasonable to assume that it is indeed changing the sequence of some mRNA that encodes a key component in terminal B-cell differentiation. That key component would then be expressed in a different form. The editing could result in an active mRNA, or the editing might result in inactivation of some inhibitor that was previously blocking progression of the B-cell differentiation program.
A second set of possibilities is that AID itself is one of the enzymatic components for the DNA recombination and mutation steps of both class switch and somatic hypermutation. AID is rather small, however -about 24 kDaand it is difficult to imagine, though not impossible, that a protein of this size could have cytidine deaminase, nuclease and mutation activities. But it could be a structural Dispatch R799
Figure 1
Possible roles for activation-induced cytidine deaminase in class switching and somatic hypermutation.
Activation-induced cytidine deaminase
Editing of mRNAs for class switch or somatic mutation enzymes component of a larger complex that acts on DNA to achieve recombination and mutation. In this regard, it is noteworthy that some RNA-editing enzymes bind preferentially to non-B-form DNA conformations [15] and that unusual nucleic acid structures form at class switch sequences when transcribed in purified systems [6, 7, 16] .
It is interesting that the enzyme apobec-1, which edits the apo B mRNA, requires another protein, the apobec-1 complementation factor (ACF), in order to bind to the apo B mRNA. Both apobec-1 and ACF are required for editing of the apo B mRNA in vitro. There is an 11 nucleotide mooring sequence that targets the editing in the apo B mRNA. ACF is expressed in other tissues, including lymphoid tissues, even though apobec-1 is not. Based on this precedent, it is conceivable that ACF or another equivalent factor helps AID recognize another mRNA containing the ACF mooring sequence that is important in B-cell differentiation or in the catalysis of class switch and somatic hypermutation.
In considering the possible roles of AID, it is worth noting that class switch recombination only occurs at the heavy chain locus at class switch sequences, whereas somatic hypermutation occurs at the kappa and lambda light chain loci as well as at the heavy chain locus. There does not appear to be a fundamental way in which switch recombination and somatic hypermutation could be linked in terms of the mechanism by which they occur. Both processes are unusual enough, however, that predictions are difficult to make.
As the B cell, class switch and somatic hypermutation fields consider these dramatic and important findings, many new avenues have been opened by the discovery of AID. It is not possible at this time to know the precise role of this enzyme in the DNA or B-cell developmental events, but it is clear that identification of AID is a major advance that will be of both basic and clinical importance in the long term.
